Analytical Data
-
Gene name
SLC25A6
- Application
-
Alternative Names
(ADP,ATP carrier protein 3)(ADP,ATP carrier protein, isoform T2)(ANT 2)(Adenine nucleotide translocator 3)(ANT 3)(Solute carrier family 25 member 6)
-
Species
Human
-
Source
E. coli
-
Tag
N- His-KSI
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
P12236
-
Expression Region
232-272aa
-
Molecular Weight
20.2 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
SLC25A6, also known as the mitochondrial aspartate/glutamate transporter, plays a pivotal role in mitochondrial metabolism by facilitating the transport of aspartate and glutamate across the mitochondrial membrane. This transporter is crucial for maintaining the balance of amino acids, which are essential for various metabolic processes, including the urea cycle and neurotransmitter synthesis. Mutations in the SLC25A6 gene have been linked to a range of mitochondrial disorders, emphasizing its significance in cellular function and overall health. Research on SLC25A6 recombinant protein focuses on elucidating its structure, function, and the mechanisms underlying its transport activity. Understanding the biochemical properties of this protein can provide insights into the pathophysiology of related diseases and potentially lead to therapeutic strategies. Furthermore, the production of recombinant SLC25A6 protein enables detailed biophysical studies and high-throughput screening, which are essential for drug discovery efforts targeting mitochondrial dysfunction. Overall, the investigation of SLC25A6 recombinant protein is fundamental to unraveling the complexities of mitochondrial biology and its implications in human disease.
